|Bid||1,635.00 x 519300|
|Ask||1,667.50 x 75000|
|Day's Range||1,641.50 - 1,655.50|
|52 Week Range||1,363.00 - 1,745.56|
|PE Ratio (TTM)||48.15|
|Dividend & Yield||1.01 (4.76%)|
|1y Target Est||N/A|
Celldex Therapeutics and Agenus have promising oncology pipelines, but which is the better stock right now?
Ionis Pharmaceuticals, Inc. (IONS) announced that the phase III study NEURO-TTR on inotersen (IONIS-TTRRx) in patients with familial amyloid polyneuropathy (FAP) met both primary endpoints.
Shares of Pfizer Inc. (NYSE: PFE ) were trading lower by nearly 2 percent Tuesday morning after analysts at Citi downgraded the stock and offered three alternative recommendations. Citi's Andrew Baum downgraded ...